Literature DB >> 10811143

Studies on the gonadotropin-releasing activity of thymulin: changes with age.

O A Brown1, Y E Sosa, M Dardenne, J M Pléau, R G Goya.   

Abstract

We assessed the ability of thymulin, a zinc-dependent nonapeptide produced by the thymic epithelial cells, to influence the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from dispersed anterior pituitary (AP) cells from young, adult, and senescent female rats. Perifusion of young and senescent AP cells with thymulin doses of 10(-6) to 10(-5) M gave a significant stimulatory response for LH but not FSH. Gonadotropin release was always lower in the senescent cells. AP cells from both age groups incubated with 10(-8) to 10(-3) M thymulin showed a time- and dose-dependent response for both gonadotropins, with a maximal stimulation at 10(-7) M. Preincubation of thymulin with an antithymulin serum completely quenched the secretagogue activity of the hormone. Coincubation of thymulin with the secretagogue gonadotropin-releasing hormone (GnRH) revealed a synergistic effect on LH release and an additive effect on the release of FSH. The calcium chelator EGTA blocked the gonadotropin-releasing activity of thymulin in AP cells. The cAMP enhancers, caffeine, NaF, and forskolin significantly increased the thymulin-stimulated release of gonadotropins. The inositol phosphate enhancer LiCl potentiated the action of thymulin on gonadotropins. It is concluded that the gonadotropin-releasing activity documented here for thymulin is an age- and receptor-dependent effect mediated in part by calcium, cAMP, and inositol phosphates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10811143     DOI: 10.1093/gerona/55.4.b170

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  7 in total

1.  Thymulin-based gene therapy and pituitary function in animal models of aging.

Authors:  Paula C Reggiani; Brenda Poch; Gloria M Cónsole; Omar J Rimoldi; Jose I Schwerdt; Victoria Tüngler; Margarita M Garcia-Bravo; Mireille Dardenne; Rodolfo G Goya
Journal:  Neuroimmunomodulation       Date:  2011-09-22       Impact factor: 2.492

2.  Neonatal thymulin gene therapy prevents ovarian dysgenesis and attenuates reproductive derangements in nude female mice.

Authors:  Paula C Reggiani; Claudio G Barbeito; Gustavo O Zuccolilli; Gloria M Cónsole; Alicia M Flamini; Mireille Dardenne; Rodolfo G Goya
Journal:  Endocrinology       Date:  2012-06-14       Impact factor: 4.736

3.  Thymulin gene therapy prevents the reduction in circulating gonadotropins induced by thymulin deficiency in mice.

Authors:  Rodolfo G Goya; Paula C Reggiani; Silvan M Vesenbeckh; Jean M Pléau; Yolanda E Sosa; Gloria M Cónsole; Rüdiger Schade; Peter Henklein; Mireille Dardenne
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-03-27       Impact factor: 4.310

4.  Partial prevention of hepatic lipid alterations in nude mice by neonatal thymulin gene therapy.

Authors:  Margarita M García de Bravo; Mónica P Polo; Paula C Reggiani; Omar J Rimoldi; Mireille Dardenne; Rodolfo G Goya
Journal:  Lipids       Date:  2006-08       Impact factor: 1.880

Review 5.  The thymus-neuroendocrine axis: physiology, molecular biology, and therapeutic potential of the thymic peptide thymulin.

Authors:  Paula C Reggiani; Gustavo R Morel; Gloria M Cónsole; Claudio G Barbeito; Silvia S Rodriguez; Oscar A Brown; Maria Jose Bellini; Jean-Marie Pléau; Mireille Dardenne; Rodolfo G Goya
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

6.  Morphological restoration of gonadotrope population by thymulin gene therapy in nude mice.

Authors:  P Reggiani; E Martines; C Ferese; R Goya; G Cónsole
Journal:  Histol Histopathol       Date:  2009-06       Impact factor: 2.303

7.  Immunomodulation of Homeopathic Thymulin 5CH in a BCG-Induced Granuloma Model.

Authors:  Leoni Villano Bonamin; Cesar Sato; Ruggero Zalla Neto; Graziela Morante; Thayná Neves Cardoso; Fabiana Rodrigues de Santana; Cideli de Paula Coelho; Lika Osugui; Ana Flavia Popi; Elizabeth Cristina Perez Hurtado; Mario Mariano
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-28       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.